Frontiers | Real-world clinical treatment outcomes in Chinese non-small cell lung cancer with EGFR exon 20 insertion mutations ✅Overall survival was significantly longer in EGFR ex20ins patients with anti-angiogenesis agents. https://t.co/thMu2KFDWA
47 followers
17,538 followers
Real-world clinical treatment outcomes in Chinese non-small cell lung cancer with EGFR exon 20 insertion mutations: Background, EGFR exon 20 insertions (EGFR ex20ins) constitute a heterogeneous subset of EGFR-activating… #oncology https://t.co/bsmZXnlF2P h
6,531 followers
New research: Real-world clinical treatment outcomes in Chinese non-small cell lung cancer with EGFR exon 20 insertion mutations: Background EGFR exon 20 insertions (EGFR ex20ins) constitute a heterogeneous subset of EGFR-activating… https://t.co/ICtSgLES